4/A: BioLife Solutions Executive Corrects Stock Sale Reporting in Amended SEC Filing
SEC Filing (Form 4/A)
Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, files an amendment to a previous Form 4 to correct the number of shares sold on March 17, 2025.
Summary
- Sarah Aebersold, Chief Human Resources Officer at BioLife Solutions, filed an amended Form 4 with the SEC on March 20, 2025.
- The amendment corrects a previous filing from March 18, 2025, which incorrectly reported the number of shares sold on March 17, 2025.
- The corrected filing shows that Aebersold sold 2,695 shares of common stock at a weighted average price of $25.44.
- The sales were executed under a pre-arranged Rule 10b5-1(c) trading plan adopted on December 11, 2024.
- Following the transaction, Aebersold beneficially owns 48,797 shares of BioLife Solutions common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing correcting a previous error. It doesn't convey any strong positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider trading activity and doesn't necessarily reflect broader industry trends. It is part of the standard regulatory requirements for company executives.
Key Dates
| Date | Description |
|---|---|
| 12-11-2024 | Date of adoption of Rule 10b5-1(c) trading plan |
| 03/17/2025 | Date of stock sale transaction |
| 03/18/2025 | Date of original Form 4 filing (incorrect) |
| 03/20/2025 | Date of amended Form 4/A filing |
Keywords
Form 4, amendment, stock sale, BioLife Solutions, BLFS, Aebersold, Rule 10b5-1(c), SEC filing, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.